Compromised Margins Following Mastectomy for Stage I-III Breast Cancer

被引：0
|
作者：
Al Mushawah, Fatema [1 ]
Aft, Rebecca L. [1 ]
Gillanders, William E. [1 ]
Eberlein, Timothy J. [1 ]
Margenthaler, Julie A. [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2011年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S162 / S162
页数：1
相关论文
共 50 条
  • [21] Aspirin Exposure and Nodal Status at Diagnosis in Women with Stage I-III Breast Cancer.
    Barron, T. I.
    Sharp, L.
    Bennett, K.
    Visvanathan, K.
    CANCER RESEARCH, 2011, 71
  • [22] A Matched Pair Cohort Study of the Effect of Neoadjuvant Chemotherapy in Stage I-III Breast Cancer
    Sprunt, J.
    Barrak, D.
    Morocco, E.
    Pan, E.
    Wu, G.
    Tung, L.
    Wecsler, J.
    Raghavendra, A.
    Ragab, O.
    Chung, E.
    Tripathy, D.
    Bhasin, M.
    Russell, C.
    Sener, S.
    Lang, J.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S48 - S48
  • [23] Effect of body mass index in the outcome of stage I-III triple negative breast cancer
    Sendur, M. A.
    Aksoy, S.
    Ozdemir, N.
    Yazici, O.
    Zengin, N.
    Altundag, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] Evaluation of micrometastatic disease after neoadjuvant chemotherapy in stage I-III breast cancer patients
    Spencer, A.
    Krishnamurthy, S.
    Lodhi, A.
    Cristofanilli, M.
    Andreopolou, E.
    Singh, B.
    Bedrosian, I.
    Meric-Bernstam, F.
    Lucci, A.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 62 - 62
  • [25] Adjuvant treatment results and prognostic factors in patients with stage I-III operated breast cancer
    Izmirli, Mustafa
    Donmez Yilmaz, Binnur
    Alan, Omur
    Yalciner, Mehmet
    Berberoglu, Elif
    Unsal, Mustafa
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2006, 21 (02): : 72 - 80
  • [26] Treatment of stage I-III periodontitis
    Reena Wadia
    British Dental Journal, 2020, 229 (6) : 375 - 375
  • [27] Clinical Profile and Outcome of Patients with Stage I-III Breast Cancer Treated at the Regional Cancer Centre, Thiruvananthapuram
    Matthew, B.
    Odungattu, Z.
    George, P. S.
    Arjunan, A.
    Kr, R.
    Ratheesan, K.
    CLINICAL ONCOLOGY, 2017, 29 (03) : E75 - E75
  • [28] Cancer-Specific Outcomes of Hypofractionated Locoregional Radiation Therapy for Patients with Stage I-III Breast Cancer
    Koulis, T. A.
    Nichol, A.
    Tyldesley, S.
    Truong, P.
    Weir, L.
    Speers, C.
    Lovedeep, G.
    Olson, R. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S79 - S79
  • [29] Treatment Patterns Among Women Diagnosed With Stage I-III Triple-negative Breast Cancer
    Sineshaw, Helmneh M.
    Freedman, Rachel A.
    DeSantis, Carol E.
    Jemal, Ahmedin
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (10): : 997 - 1007
  • [30] Correlation of COX-2 in stage I-III triple receptor-negative breast cancer
    Mosalpuria, K.
    Krishnamurthy, S.
    Cristofanilli, M.
    Bedrosian, I.
    Meric-Bernstam, F.
    Singh, B.
    Lucci, A.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 43 - 43
12345